Häggström C, Van Hemelrijck M, Garmo H, Robinson D, Stattin P, Rowley M, Coolen ACC, Holmberg L. Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and type 2 diabetes mellitus, Int J Cancer. May 9 2018. Sammanfattning

Jansson F, Drevin L, Frisell T, Stattin P, Bratt O, Akre O. Concordance of Non-Low-Risk Disease Among Pairs of Brothers With Prostate Cancer, J Clin Oncol. Apr 13 2018. Sammanfattning

Russell B, Garmo H, Beckmann K, Stattin P, Adolfsson J, Van Hemelrijck M. A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0, PLoS One. Apr 12 2018. Sammanfattning

Stattin P, Sandin F, Loeb S, Robinson D, Franck Lissbrant I, Lambe M. Public online reporting from a nationwide population-based clinical prostate cancer register, BJU Int. Mar 25 2018. Sammanfattning

Data quality in the National Prostate Cancer Register (NPCR) of Sweden. Katarina Tomic
Umeå University Dissertations New Series No 1945. ISSN 0346-6612
Data quality in NPCR

Gnanapragasam VJ, Bratt O, Muir K, Lee LS, Huang HH, Stattin P, Lophatananon A. The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study, BMC Med. Feb 28 2018. Sammanfattning

Franck Lissbrant I, Ventimiglia E, Robinson D, Törnblom M, Hjälm-Eriksson M, Lambe M, Folkvaljon Y, Stattin P. Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in Sweden, Scand J Urol. Feb 1 2008. Sammanfattning

Tomic K, Ventimiglia E, Robinson D, Häggström C, Lambe M, Stattin P. Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population-based study, Int J Cancer. Jan 24 2018. Sammanfattning

Arthur R, Williams R, Garmo H, Holmberg L, Stattin P, Malmström H, Lambe M, Hammar N, Walldius G, Robinsson D, Jungner I, Van Hemelrijck M. Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study, Int J Cancer. Jan 11 2018. Sammanfattning

Stattin P, Franck Lissbrant I. Diagnosspecifika översikter är viktiga vertyg för cancervården, Lakartidningen. Jan 9 2008. Sammanfattning

FitzGerald LM, Zhao S, Leonardson A, Geybels MS, Kolb S, Lin DW, Wright JL, Eeles R, Kote-Jarai Z, Govindasami K, Giles GG, Southey MC, Schleutker J, Tammela TL, Sipeky C, Penney KL, Stampfer MJ, Gronberg H, Wiklund F, Stattin P, Hugosson J, Karyadi DM, Ostrander EA, Feng Z, Stanford JL. Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases. Prostate Cancer Prostatic Dis. Jan 3 2018. Sammanfattning

Lycken M, Drevin L, Garmo H, Stattin P, Adolfsson J, Lissbrant IF, Holmberg L, Bill-Axelson A. The use of palliative medications before death from prostate cancer: Swedish population-based study with a comparative overview of European data, Eur J Cancer. Jan 2018. Sammanfattning

Robinson D, Garmo H, Lissbrant IF, Widmark A, Pettersson A, Gunnlaugsson A, Adolfsson J, Bratt O, Nilsson P, Stattin P. Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study, Eur Urol. Dec 15 2017. Sammanfattning